Cargando…
Measuring hsCRP—An Important Part of a Comprehensive Risk Profile or a Clinically Redundant Practice?
James McCormack and Michael Allan discuss issues and questions surrounding hsCRP measurements in patients.
Autores principales: | McCormack, James P., Allan, G. Michael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2814824/ https://www.ncbi.nlm.nih.gov/pubmed/20126381 http://dx.doi.org/10.1371/journal.pmed.1000196 |
Ejemplares similares
-
Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels
por: Ping, Fan, et al.
Publicado: (2022) -
HsCRP in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Alavi, S A, et al.
Publicado: (2011) -
IL-6 and hsCRP in Somatic Symptom Disorders and related disorders
por: van der Feltz-Cornelis, Christina M., et al.
Publicado: (2020) -
Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study
por: Best, Lyle G., et al.
Publicado: (2019) -
GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)